Overview

A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI)

Status:
Withdrawn
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This investigation will explore the impact of 8 weeks of citicoline treatment on cognitive function, clinical state and substance use in 40 individuals with mild traumatic brain injury (mTBI).
Phase:
Phase 2
Details
Lead Sponsor:
Mclean Hospital
Treatments:
Cytidine Diphosphate Choline